Exeporfinium chloride (XF-73) nasal gel significantly reduces Staphylococcus aureus nasal carriage in cardiac surgery patients throughout surgery and the early recovery period: results from a randomized placebo-controlled Phase 2 study.
Saved in:
| Title: | Exeporfinium chloride (XF-73) nasal gel significantly reduces Staphylococcus aureus nasal carriage in cardiac surgery patients throughout surgery and the early recovery period: results from a randomized placebo-controlled Phase 2 study. |
|---|---|
| Authors: | Mangino JE; Division of Infection Diseases, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Firstenberg MS; Department of Surgery, Maui Memorial Medical Center, Maui, HI, USA., Rhys-Williams W; Destiny Pharma plc, Brighton, UK., Lees JP; Formerly at Destiny Pharma plc, Brighton, UK., Dane A; Danestat Consulting Ltd., Macclesfield, UK., Love WG; Destiny Pharma plc, Brighton, UK., Gonzalez Moreno J; Formerly at Destiny Pharma plc, Brighton, UK., Martina Y; Formerly at Destiny Pharma plc, Brighton, UK., Barker D; Destiny Pharma plc, Brighton, UK. |
| Source: | Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2024 Nov; Vol. 45 (11), pp. 1355-1357. Date of Electronic Publication: 2024 Oct 10. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cambridge University Press Country of Publication: United States NLM ID: 8804099 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-6834 (Electronic) Linking ISSN: 0899823X NLM ISO Abbreviation: Infect Control Hosp Epidemiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39387200 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Exeporfinium chloride (XF-73) nasal gel significantly reduces Staphylococcus aureus nasal carriage in cardiac surgery patients throughout surgery and the early recovery period: results from a randomized placebo-controlled Phase 2 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mangino+JE%22">Mangino JE</searchLink>; Division of Infection Diseases, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Firstenberg+MS%22">Firstenberg MS</searchLink>; Department of Surgery, Maui Memorial Medical Center, Maui, HI, USA.<br /><searchLink fieldCode="AU" term="%22Rhys-Williams+W%22">Rhys-Williams W</searchLink>; Destiny Pharma plc, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Lees+JP%22">Lees JP</searchLink>; Formerly at Destiny Pharma plc, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Dane+A%22">Dane A</searchLink>; Danestat Consulting Ltd., Macclesfield, UK.<br /><searchLink fieldCode="AU" term="%22Love+WG%22">Love WG</searchLink>; Destiny Pharma plc, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Gonzalez+Moreno+J%22">Gonzalez Moreno J</searchLink>; Formerly at Destiny Pharma plc, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Martina+Y%22">Martina Y</searchLink>; Formerly at Destiny Pharma plc, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Barker+D%22">Barker D</searchLink>; Destiny Pharma plc, Brighton, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228804099%22">Infection control and hospital epidemiology</searchLink> [Infect Control Hosp Epidemiol] 2024 Nov; Vol. 45 (11), pp. 1355-1357. <i>Date of Electronic Publication: </i>2024 Oct 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cambridge+University+Press%22">Cambridge University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8804099 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-6834 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220899823X%22">0899823X </searchLink><i>NLM ISO Abbreviation: </i>Infect Control Hosp Epidemiol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39387200 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1017/ice.2024.122 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1355 Titles: – TitleFull: Exeporfinium chloride (XF-73) nasal gel significantly reduces Staphylococcus aureus nasal carriage in cardiac surgery patients throughout surgery and the early recovery period: results from a randomized placebo-controlled Phase 2 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mangino JE – PersonEntity: Name: NameFull: Firstenberg MS – PersonEntity: Name: NameFull: Rhys-Williams W – PersonEntity: Name: NameFull: Lees JP – PersonEntity: Name: NameFull: Dane A – PersonEntity: Name: NameFull: Love WG – PersonEntity: Name: NameFull: Gonzalez Moreno J – PersonEntity: Name: NameFull: Martina Y – PersonEntity: Name: NameFull: Barker D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2024 Nov Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1559-6834 Numbering: – Type: volume Value: 45 – Type: issue Value: 11 Titles: – TitleFull: Infection control and hospital epidemiology Type: main |
| ResultId | 1 |
